
Jan 12 (Reuters) - Medtronic has "significant firepower" to pursue acquisitions as the medical device maker evaluates opportunities to expand its portfolio, executives said at a major industry conference that kicked off on Monday in San Francisco.
The medical device maker has been eyeing tuck-in deals as it seeks to diversify its portfolio, particularly in cardiology and neuroscience, with CEO Geoff Martha in November saying that they would prefer companies in "early stage or close to market."
The company's balance sheet gives it flexibility to execute a "meaningful number" of transactions without financial strain, Chief Financial Officer Thierry Piéton said at the J.P. Morgan healthcare conference on Monday.
"What's changing versus the last few years is coming back to doing more M&A," he said, adding that Medtronic's dividend policy remains unchanged.
Medtronic, which makes devices ranging from pacemakers to insulin pumps, reported a 3.7% rise in revenue to $33.6 billion in fiscal 2025.
The company is targeting deals in the low- to mid-single-digit billions of dollars, choosing targets that will supplement its internal R&D efforts, Martha said on Monday. The company has set up a new committee at the board level to move faster on deals, he added.
The executives said Medtronic is focused on two themes, expanding in areas where it already competes and acquiring enabling technologies for procedures such as cardiac ablation and surgical robotics.
The company has spent recent years improving operations by divesting non-core units and plans to spin off its diabetes business as MiniMed Group through a U.S. initial public offering following its struggles over the last few years.
It also added two new directors to its board last year after activist investor Elliott Investment Management emerged as one of its largest shareholders.
Medtronic now sees itself positioned to pursue strategic opportunities.
"We've earned the right to do these acquisition, and we've got the capacity, so we're going to step up," Piéton said.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Alan Barona and Leroy Leo)
LATEST POSTS
- 1
Schools to start reopening after Nigeria mass abduction - 2
Novartis to build manufacturing hub in North Carolina, creating 700 jobs - 3
Brazil passes anti-gang law allowing seized crypto to fund security forces - 4
Benin coup thwarted by loyalist troops, president tells nation - 5
UN rights chief: Israel's new Gaza aid agency rules 'outrageous'
Merck urges science-led US vaccine schedule after CDC trims childhood vaccine list
Family Matters: Tips and Guidance for Effective Nurturing and Everyday Life
Bombardier Global 8000 Enters Service
This Week In Space podcast: Episode 186 — Snow on the Moon?
Exclusive-Drugmakers raise US prices on 350 medicines despite pressure from Trump
Report: Russian military pressuring students to work as drone pilots
Exploring the Market: Unsold Rams May Be Less expensive Than You Naturally suspect
RFK Jr. guts the US childhood vaccine schedule despite its decades-long safety record
Enormous Credit And All that You Really want To Be aware













